Verition Fund Management’s Mesoblast MESO Stock Holding History

Verition Fund Management’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-28,844	Closed	-$314K	–	3908
2025 Q2	$314K	Buy	+28,844	New	+$323K	﹤0.01%	3178

Other funds holding MESO

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Verition Fund Management's MESO Position: Q3 2025 in Review

Verition Fund Management sold out of Mesoblast (MESO) in Q3 2025, closing a stake of 28,844 shares — an estimated $314K sold.

Verition Fund Management first reported a position in MESO in Q2 2025 and held it in 1 quarter. The position peaked at $314K in Q2 2025. 68 funds tracked by Wall St. Rank hold MESO as of Q3 2025.

Verition Fund Management reported no remaining Mesoblast position as of Q3 2025 after selling out during the quarter.
Verition Fund Management sold 28,844 Mesoblast shares in Q3 2025, an estimated $314K.
Verition Fund Management first reported a position in Mesoblast in Q2 2025 and held it in 1 quarter.
Verition Fund Management's Mesoblast position peaked at $314K in Q2 2025.
68 funds tracked by Wall St. Rank held Mesoblast as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.